Latest Headlines

• 

  Is This FDA Investigation Bad News for Drug Makers?

  Meghan Foley   | Thu, Mar 14 |  Comment
• 

  Boeing’s Test Flight and the FDA’s Rejection: Morning Buzzers

  Dan Ritter   | Mon, Feb 11 |  Comment
• 

  Is Forest Laboratories a Buy Now?

  Dan Moskowitz   | Tue, Jan 15 |  Comment
• 

  Gilead's Positive Results, Novo Nordisk's New Insulin Data: Healthcare Business Recap

  Mark Lawson   | Tue, Nov 27 |  Comment
• 

  Drug Firms Race To Reduce LDL, Novo Nordisk Awaits FDA Vote: Healthcare Business Recap

  Mark Lawson   | Tue, Nov 6 |  Comment
• 

  News Corp and Sirius XM Among Sizzling Stocks Achieving 52-Week Highs

  Deann Marin   | Mon, Oct 22 |  Comment
• 

  Healthcare Business Update: Pfizer Pays to End Suit, Amarin's FDA Decision Put Off

  Mark Lawson   | Thu, Oct 11 |  Comment
• 

  Healthcare Business Update: Hain's NEW Credit Facility, Medivation Scores GOOD NEWS

  Mark Lawson   | Tue, Sep 4 |  Comment
• 

  Healthcare Recap: Centene and Molina ROCKET Higher

  Mark Lawson   | Sun, Jun 10 |  Comment
• 

  Healthcare Business Review: Keryx Biopharmaceuticals Tanks, GlaxoSmithKline Better Than Merck

  Mark Lawson   | Mon, Apr 2 |  Comment